Perioperative care for patients with rheumatic diseases

Nature Reviews Rheumatology

Volumn 8, Issue 1, 2012, Pages 32-41

  Veetil, Bharath M Akkara ^a   Bongartz, Tim ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; TUMOR NECROSIS FACTOR INHIBITOR;

ADRENAL INSUFFICIENCY; BLEEDING; CARDIOVASCULAR RISK; CLINICAL DECISION MAKING; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FUNCTIONAL ASSESSMENT; HUMAN; INFECTION RISK; PATIENT ASSESSMENT; PATIENT CODING; PERIOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SURGICAL INFECTION; SURGICAL RISK; THROMBOPHILIA; TREATMENT WITHDRAWAL; WOUND HEALING IMPAIRMENT;

ALGORITHMS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; GLUCOCORTICOIDS; GUIDELINES AS TOPIC; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; PERIOPERATIVE CARE; PERIOPERATIVE PERIOD; RHEUMATIC DISEASES; RISK FACTORS; SOCIETIES, MEDICAL; WITHHOLDING TREATMENT;

EID: 84655169655     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.171     Document Type: Review

References (72)

1. Peters, M. J., van der Horst-Bruinsma, I. E., Dijkmans, B. A. & Nurmohamed, M. T. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin. Arthritis Rheum. 34, 585-592 (2004). (Pubitemid 39643120)
2. Urowitz, M. B. et al. The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 60, 221-225 (1976).
3. Maradit-Kremers, H. et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 52, 402-411 (2005). (Pubitemid 40220344)
4. Meune, C., Touzé, E., Trinquart, L. & Allanore, Y Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 48, 1309-1313 (2009).
5. Fleisher, L. A. et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery) developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J. Am. Coll. Cardiol. 50, 1707-1732 (2007).
6. Backer, C. L., Tinker, J. H., Robertson, D. M. & Vlietstra, R. E. Myocardial reinfarction following local anesthesia for ophthalmic surgery. Anesth. Analg. 59, 257-262 (1980). (Pubitemid 10098882)
7. Warner, M. A., Shields, S. E. & Chute, C. G. Major morbidity and mortality within 1 month of ambulatory surgery and anesthesia. JAMA 270, 1437-1441 (1993). (Pubitemid 23273751)
8. Nelson, C. L. et al. Relation of clinical and angiographic factors to functional capacity as measured by the Duke Activity Status Index. Am. J. Cardiol. 68, 973-975 (1991).
9. Gerson, M. C. et al. Cardiac prognosis in noncardiac geriatric surgery. Ann. Intern. Med. 103, 832-837 (1985). (Pubitemid 16175491)
10. Lindhardsen, J. et al. The risk of myocardial infarction in rheumatoid arthritis and diabetes mellitus: a Danish nationwide cohort study. Ann. Rheum. Dis. 70, 929-934 (2011).
11. Peters, M. J. et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann. Rheum. Dis. 69, 325-331 (2010).
12. Yazdanyar, A. et al. Rheumatoid arthritis increases risk of perioperative cardiovascular events: an analysis using the national inpatient sample of the Healthcare Cost and Utilization Project [abstract 1035-189]. J. Am. Coll. Cardiol. 51, A361 (2008).
13. Yazdanyar, A., Wasco, M. C., Kraemer, K. L. & Ward, M. M. Hospital-based surgical procedures and the risk of perioperative cardiovascular events: a comparison study of rheumatoid arthritis and diabetes mellitus using the national inpatient sample of the Healthcare Cost and Utilization Project [abstract]. Arthritis Rheum. 62 (Suppl. 10), 1039 (2010).
14. Cinà, C. S. & Devereaux, P. J. Coronary-artery revascularization before elective major vascular surgery. Vasc. Med. 11, 61-63 (2006).
15. Mangano, D. T., Layug, E. L., Wallace, A. & Tateo, I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N. Engl. J. Med. 335, 1713-1720 (1996). (Pubitemid 26399345)
16. Smitten, A. L. et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J. Rheumatol. 35, 387-393 (2008). (Pubitemid 351374409)
17. Kirwan, J. R. et al. The effect of therapeutic glucocorticoids on the adrenal response in a randomized controlled trial in patients with rheumatoid arthritis. Arthritis Rheum. 54, 1415-1421 (2006).
18. Kehlet, H. & Binder, C. Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Br. Med. J. 2, 147-149 (1973).
19. Coursin, D. B. & Wood, K. E. Corticosteroid supplementation for adrenal insufficiency. JAMA 287, 236-240 (2002). (Pubitemid 34251950)
20. Doran, M. F., Crowson, C. S., Pond, G. R., O'Fallon, W. M. & Gabriel, S. E. Predictors of infection in rheumatoid arthritis. Arthritis Rheum. 46, 2294-2300 (2002).
21. Smitten, A. L. et al. The risk of hospitalized infection in patients with rheumatoid arthritis. J. Rheumatol. 35, 387-393 (2008). (Pubitemid 351374409)
22. Stuck, A. E., Minder, C. E. & Frey, F. J. Risk of infectious complications in patients taking glucocorticosteroids. Rev. Infect. Dis. 11, 954-963 (1989).
23. Grennan, D. M. et al. Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery. Ann. Rheum. Dis. 60, 214-217 (2001). (Pubitemid 32260601)
24. Murata, K. et al. Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery. Mod. Rheumatol. 16, 14-19 (2006).
25. den Broeder, A. A. et al. Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study. J. Rheumatol. 34, 689-695 (2007). (Pubitemid 46641372)
26. Kawakami, K. et al. Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-α blockers: perioperative interruption of tumour necrosis factor-α blockers decreases complications- Rheumatology (Oxford) 49, 341-347 (2010).
27. Giles, J. T. et al. Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis. Arthritis Care Res. 55, 333-337 (2006).
28. Ruyssen-Witrand, A. et al. Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers. Clin. Exp. Rheumatol. 25, 430-436 (2007). (Pubitemid 47091020)
29. Dutch Society for Rheumatology. Medicines: the application of TNF blockade in the treatment of rheumatoid arthritis [online] www.nvr.nl (2003).
30. Ledingham, J. et al. Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001). Rheumatology (Oxford) 44, 157-163 (2005). (Pubitemid 40277395)
31. Bongartz, T. et al. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA 295, 2275-2285 (2006). (Pubitemid 43736578)
32. Dixon, W. G. et al. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum. 54, 2368-2376 (2006). (Pubitemid 44204996)
33. Keystone, E. C. Does anti-tumor necrosis factor-α therapy affect risk of serious infection and cancer in patients with rheumatoid arthritis-: a review of longterm data. J. Rheumatol. 38, 1552-1562 (2011).
34. Appau, K. A. et al. Use of infliximab within 3 months of ileocolonic resection is associated with adverse postoperative outcomes in Crohn's patients. J. Gastrointest. Surg. 12, 1738-1744 (2008).
35. Bongartz, T. Elective orthopedic surgery and perioperative DMARD management: many questions, fewer answers, and some opinions. J. Rheumatol. 34, 653-655 (2007). (Pubitemid 46641364)
36. Drenkard, C. et al. Influence of the antiphospholipid syndrome in the survival of patients with systemic lupus erythematosus. J. Rheumatol. 21, 1067-1072 (1994). (Pubitemid 24182280)
37. Asherson, R. A. et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 68, 366-374 (1989). (Pubitemid 19286656)
38. Sneddon, I. B. Cerebro-vascular lesions and lvedo reticularis. Br. J. Dermatol. 77, 180-185 (1965).
39. Wahl, D. G. et al. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 7, 15-22 (1998). (Pubitemid 28052657)
40. Emir, M. et al. Dural sinus thrombosis after cardiopulmonary bypass. Perfusion 19, 133-135 (2004). (Pubitemid 38607517)
41. Berkun, Y., Elami, A., Meir, K., Mevorach, D. & Naparstek, Y. Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J. Thorac. Cardiovasc. Surg. 127, 414-420 (2004). (Pubitemid 38176645)
42. Erkan, D., Bateman, H. & Lockshin, M. D. Lupus anticoagulant- hypoprothrombinemia syndrome associated with systemic lupus erythematosus: report of 2 cases and review of literature. Lupus 8, 560-564 (1999). (Pubitemid 29452571)
43. Merrill, J. T. & Asherson, R. A. Catastrophic antiphospholipid syndrome. Nat Clin. Pract. Rheumatol. 2, 81-89 (2006). (Pubitemid 43239207)
44. th Edition). Chest 133 (6 Suppl.), 299S-339S (2008) (Pubitemid 351894915)
45. National Institute for Health and Clinical Excellence (NICE). CG92: Venous thromboembolism\-reducing the risk [online], http://guidance.nice.org.uk/ CG92/Guidance (2011).
46. Crowther, M. A. et al. A comparison of two intensities of warfarin for the prevention of recurrent thrombosis in patients with the antiphospholipid antibody syndrome. N. Engl. J. Med. 349, 1133-1138 (2003). (Pubitemid 37122325)
47. Khamashta, M. A. et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N. Engl. J. Med. 332, 993-997 (1995).
48. Hunt, B. J. The prevention of hospital-acquired venous thromboembolism in the United Kingdom. Br. J. Haematol. 144, 642-652 (2009).
49. th Edition). Chest 133 (6 Suppl.), 257S-298S (2008). (Pubitemid 351892969)
50. Erkan, D., Leibowitz, E., Berman, J. & Lockshin, M. D. Perioperative medical management of antiphospholipid syndrome: hospital for special surgery experience, review of iterature, and recommendations. J. Rheumatol. 29, 843-849 (2002). (Pubitemid 34303882)
51. Spyropoulos, A. C. et al. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry). Am. J. Cardiol. 102, 883-889 (2008).
52. Katholi, R. E., Nolan, S. P. & McGuire, L. B. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am. Heart J. 96, 163-165 (1978). (Pubitemid 8390630)
53. Strebel, N., Prins, M., Agnelli, G. & Büller, H. R. Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery- Arch. Intern. Med. 162, 1451-1456 (2002). (Pubitemid 34747477)
54. Douketis, J. D., Johnson, J. A. & Turpie, A. G. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen. Arch. Intern. Med. 164, 1319-1326 (2004). (Pubitemid 38828883)
55. Kakkos, S. K. et al. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high-risk patients. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD005258. doi:10.1002/14651858.CD005258.pub2 (2008).
56. Payne, D. A. et al. Combined therapy with clopidogrel and aspirin significantly increases the bleeding time through a synergistic antiplatelet action. J. Vasc. Surg. 35, 1204-1209 (2002). (Pubitemid 44718523)
57. Burger, W., Chemnitius, J. M., Kneissl, G. D. & Rücker, G. Low-dose aspirin for secondary cardiovascular prevention\-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation\-review and meta-analysis. J. Intern. Med. 257, 399-414 (2005). (Pubitemid 40604544)
58. Iakovou, I. et al. Incidence, predictors, and outcome of thrombosis after successful mplantation of drug-eluting stents. JAMA 293, 2126-2130 (2005). (Pubitemid 40617065)
59. Abualsaud, A. O. & Eisenberg, M. J. Perioperative management of patients with drug-eluting stents. JACC Cardiovasc. Interv. 3, 131-142 (2010).
60. Munster, T & Furst, D. E. Pharmacotherapeutic strategies for disease-modifying antirheumatic drug (DMARD) combinations to treat rheumatoid arthritis (RA). Clin. Exp. Rheumatol. 17 (6 Suppl. 18), S29-S36 (1999). (Pubitemid 29503354)
61. Bibbo, C., Anderson, R. B., Davis, W. H. & Norton, J. Rheumatoid nodules and postoperative complications. Foot Ankle Int. 24, 40-44 (2003). (Pubitemid 36077641)
62. Jain, A., Witbreuk, M., Ball, C. & Nanchahal, J. Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery. J. Hand Surg. Am. 27, 449-455 (2002). (Pubitemid 34522572)
63. Carpenter, M. T., West, S. G., Vogelgesang, S. A. & Casey Jones, D. E. Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy. Orthopedics 19, 207-210 (1996). (Pubitemid 26089384)
64. Escalante, A. & Beardmore, T. D. Risk factors for early wound complications after orthopedic surgery for rheumatoid arthritis. J. Rheumatol. 22, 1844-1851 (1995).
65. Kasdan, M. L. & June, L. Postoperative results of rheumatoid arthritis patients on methotrexate at the time of reconstructive surgery of the hand. Orthopedics 16, 1233-1235 (1993). (Pubitemid 23335950)
66. Sany, J. et al. Influence of methotrexate on the frequency of postoperative infectious complications in patients with rheumatoid arthritis. J. Rheumatol. 20, 1129-1132 (1993). (Pubitemid 23278162)
67. Perhala, R. S., Wilke, W. S., Clough, J. D. & Segal, A. M. Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate. Arthritis Rheum. 34, 146-152 (1991).
68. Bridges, S. L. Jr, López-Méndez, A., Han, K. H., Tracy, I. C. & Alarcón, G. S. Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis- J. Rheumatol. 18, 984-988 (1991).
69. Hirano, Y. et al. Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis. Clin. Rheumatol. 29, 495-500 (2010).
70. Talwalkar, S. C., Grennan, D. M., Gray, J., Johnson, P. & Hayton, M. J. Tumour necrosis factor α antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery. Ann Rheum. Dis. 64, 650-651 (2005). (Pubitemid 40469105)
71. Wendling, D. et al. Surgery in patients receiving anti-tumour necrosis factor α treatment in rheumatoid arthritis: an observational study on 50 surgical procedures. Ann. Rheum. Dis. 64, 1378-1379 (2005). (Pubitemid 41206266)
72. Bibbo, C. & Goldberg, J. W. Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy. Foot Ankle Int. 25, 331-335 (2004). (Pubitemid 39096154)